Tempus AI News - July 2026
Tempus AI's second quarter revenue rose 22% as it swung to a surprise profit and raised its 2026 outlook.
Tempus AI reported second quarter revenue of $382.5 million, a 22% increase year-over-year, and a significant beat on profitability with a GAAP EPS of $0.03...
Tempus AI, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Tempus AI is projected to report Q2 2026 revenue of $381.6 million and an EPS loss of $0.41, with its current share price of $43.96 trading significantly below...
Tempus AI to Acquire Personalis for $1.5 Billion to Expand Cancer Monitoring
Tempus AI (TEM) announced it has entered into a definitive agreement to acquire Personalis, Inc. (PSNL) for a total enterprise value of $1.5 billion. The...
Tempus AI to acquire Personalis for $1.5B, expanding cancer monitoring tech
Tempus AI (NASDAQ: TEM) signed a definitive agreement to acquire Personalis, Inc. (NASDAQ: PSNL) for approximately $1.5 billion. The deal values Personalis at...
🟢 TEM is trading 4.3% up today on strong Q1 results and AI healthcare optimism
TEM is trading 4.3% up today at $60.40 as strong Q1 2026 results and AI healthcare optimism extend a multi-day rally from the mid-$40s. • The company reported...